Orthofix saw first quarter 2025 sales grow, according to financial results posted May 6.
Five things to know about Q1:
1. Orthofix’s sales, including its recently discontinued M6-C and M6-L disc, were $193.6 million. Excluding M6 sales, Orthofix’s quarterly revenue grew 3.9% with $189.2 million.
2. Global spine sales of $159 million represent a 3% increase year over year.
3. Global orthopedic sales increased 9.1% year over year with $29.8 million.
4. Orthofix operated with a net loss of $53.1 million. That net loss grew year over year compared to a $36 million net loss in the same time last year.
5. Orthofix projects its full year revenue to reach $808 million to $816 million, excluding M6 sales.
